Energy Transfer LP (ET) Stock News

The iShares Expanded Tech-Software ETF (IGV) has declined 11% this year amid AI disruption concerns, but recent momentum loss in the AI infrastructure boom could present a buying opportunity. Rising chip costs have forced companies to cut AI spending, and reports show businesses are hiring more humans and routing tasks to cheaper AI models, potentially easing pressure on legacy software vendors.

The Vanguard Dividend Appreciation ETF (VIG) is recommended for investors seeking dividend income with lower risk. The fund tracks U.S. companies that have increased dividends for at least 10 consecutive years, offering low costs (0.04% expense ratio) and stable income rather than maximum yields. While it provides diversification and long-term growth potential, it remains subject to market volatility.

GraniteShares announced weekly distributions for 31 YieldBOOST ETFs tracking various assets including cryptocurrencies, technology stocks, and broad market indices. The distributions range from $0.0095 to $0.3124 per share with distribution rates varying from 2.06% to 95.94%. The company emphasizes that distributions are not guaranteed and may vary significantly, with the strategy involving put option writing that caps upside potential while exposing investors to downside risk.

The Vanguard Health Care ETF (VHT) offers broad healthcare exposure with a low 0.09% expense ratio and 423 holdings, while the Invesco Biotechnology & Genome ETF (PBE) provides focused biotech exposure with 31 holdings and higher growth potential. PBE delivered a stronger 40.88% one-year return but experienced greater volatility with a 37.84% maximum drawdown, while VHT returned 27.85% with lower risk. VHT suits conservative investors seeking steady, low-cost exposure, while PBE appeals to risk-tolerant investors chasing biotech innovation.

Defiance ETFs announced a prospectus supplement for its Drone & Modern Warfare ETF (JEDI) effective August 6, 2026, permitting up to 15% investment in privately issued securities of drone and warfare companies. The management fee remains at 0.69%, with total annual expenses estimated at 0.99% including a one-time SPV access fee. Brendan Cavanaugh, CFA and Chief Strategy Officer, has been added to the portfolio management team.

Rosen Law Firm reminds investors of the August 3, 2026 deadline to join a securities class action against Badger Meter, Inc. The lawsuit alleges that defendants made materially false and misleading statements about the company's financial results and growth prospects. According to the complaint, Badger Meter artificially inflated results by pulling forward customer orders to recognize revenue early, which concealed weakening demand and deteriorating order trends.

Forward Industries, a Solana-focused digital asset treasury company, announced it will host a conference call on August 12, 2026, at 5:00 p.m. ET to discuss its fiscal Q3 2026 financial results and provide updates on its SOL treasury strategy. The company, backed by Galaxy Digital and Jump Crypto, plans to release financial results prior to the call.

Vanguard research suggests international developed-market stocks may outperform U.S. stocks over the next 10 years. The Vanguard International High Dividend Yield ETF (VYMI) has beaten the S&P 500 over the past five years, offering value stocks with strong dividends at a 42% P/E discount compared to the S&P 500. The fund provides diversification away from U.S. tech-heavy portfolios.

OptimizeRx Corp. (Nasdaq: OPRX) announced it will hold a conference call on August 12, 2026, at 4:30 p.m. ET to discuss its second quarter 2026 financial results ended June 30, 2026. The call will include management remarks followed by a Q&A session, with details and webcast access provided for investors.

The article compares two real estate ETFs: RWR, which offers broader diversification across 97 REIT holdings with a 0.25% expense ratio, and XLRE, which focuses on 31 S&P 500 real estate companies with a lower 0.08% expense ratio. RWR has outperformed XLRE significantly over the past year (25.08% vs 10.60% return), benefiting from exposure to smaller and mid-cap REITs outside the S&P 500. The choice depends on investor preference: XLRE suits those wanting lower costs and blue-chip concentration, while RWR appeals to those seeking broader real estate exposure despite higher fees.

JPMorgan ETFs (Ireland) ICAV announced changes to be made to four sub-funds: EUR Aggregate Bond Active UCITS ETF, EUR Government Bond Active UCITS ETF, Global Government Bond Active UCITS ETF, and Global IG Corporate Bond Active UCITS ETF. Shareholders are directed to review the complete notice for available options.

Vanguard Health Care ETF (VHT) outperforms VanEck Biotech ETF (BBH) with lower fees (0.09% vs 0.35%), higher dividend yield (1.6% vs 0.5%), and superior 5-year returns ($1,278 vs $1,004 on $1,000 invested). VHT offers broad diversification across 411 healthcare holdings, while BBH provides concentrated biotech exposure with 25 stocks and higher volatility.

The Schwab U.S. Dividend Equity ETF (SCHD) and Vanguard Dividend Appreciation ETF (VIG) have delivered similar returns over the past decade (12.4% and 12.8% annually, respectively), but employ different strategies. SCHD screens for balance sheet health, yield, and dividend growth, while VIG focuses solely on 10+ years of dividend growth history with market-cap weighting. Despite SCHD being the superior dividend ETF overall, VIG is expected to outperform over the next 20 years due to its greater growth and tech sector exposure.

YieldMax ETFs announced weekly distributions for its Group 1 option income ETFs on July 28, 2026, with ex-dividend and record dates of July 29, 2026, and payment date of July 30, 2026. The announcement includes 11 ETFs with varying distribution rates ranging from 26.17% to 60.34%, though distributions are not guaranteed and may vary significantly.

The Schwab U.S. Dividend Equity ETF (SCHD) is recommended as the best dividend ETF for long-term investors seeking a 20-year income strategy. Unlike the Vanguard Dividend Appreciation ETF (VIG) and iShares Core Dividend Growth ETF (DGRO), SCHD maintains better sector balance and prioritizes dividend yield and fundamental value, with top holdings in stable consumer staples like Coca-Cola, Merck, Chevron, and Procter & Gamble that will remain relevant over decades.

Vanguard's VDC and First Trust's FTXG are both defensive ETFs investing in consumer staples, but with different approaches. VDC offers broader diversification across 103 stocks with a lower 0.09% expense ratio and stronger 5-year returns, while FTXG concentrates on 30 food and beverage companies with a higher 2.59% dividend yield but higher 0.60% expense ratio. For most long-term investors, VDC is the more straightforward choice due to lower costs and better diversification.

While Micron Technology stock has surged 671% over the past year, its steep valuation and high share price make it less attractive for some investors. The Roundhill Memory ETF (DRAM) offers a more accessible alternative at ~$50/share, providing diversified exposure to memory leaders including Micron, SK Hynix, and others. The global semiconductor memory market is projected to grow significantly from $190 billion in 2026 to $448 billion by 2034.

JETOUR Auto has partnered with Discovery to co-produce Season 2 of Adventure of Extremes and sponsor Marooned with Ed Stafford, marking the first collaboration between world-renowned explorer Ed Stafford and an automotive brand. The JETOUR G700 will serve as the official vehicle for extreme expeditions across multiple continents, with episodes launching in August 2026 to demonstrate the vehicle's off-road capabilities.

The Schwab U.S. REIT ETF (SCHH) provides a low-cost domestic REIT option with a 0.07% expense ratio, while the iShares Global REIT ETF (REET) offers broader diversification across developed and emerging markets at 0.14% expense ratio. REET offers higher dividend yield (3.36%) but comes with additional currency and regional risks, making the choice dependent on whether investors want simple U.S. exposure or global diversification.

Following the announcement of its proposed merger with WDP, Standard & Poor's has placed ARGAN's BBB- credit rating on CreditWatch with positive outlook, signaling a potential upgrade of at least one notch. S&P cited the merger's expected benefits including increased size, strengthened rental income profile, expanded geographic diversification, and reduced client concentration risk, positioning the combined entity as a European logistics real estate leader.

The State Street Health Care Select Sector SPDR ETF (XLV) and Fidelity MSCI Health Care Index ETF (FHLC) both offer low-cost healthcare exposure with identical 0.08% expense ratios. XLV focuses on 60 mega-cap healthcare stocks and has delivered stronger 5-year returns ($1,332 vs $1,276 on $1,000 invested), higher dividend yield (1.60% vs 1.30%), and greater liquidity with $41.7B in AUM. FHLC provides broader diversification with 365 holdings including mid and small-cap stocks. Over 10 years, both underperformed the S&P 500 significantly, with XLV returning 157% (9.9% CAGR) and FHLC returning 159% (10.0% CAGR) versus the S&P 500's 301% (14.9% CAGR).

While the Schwab U.S. Dividend Equity ETF (SCHD) remains a popular dividend ETF with a 3.3% yield and low 0.06% expense ratio, the First Trust Rising Dividend Achievers ETF (RDVY) has significantly outperformed it over the past decade, delivering 15.96% annual returns versus SCHD's 12.5%. However, RDVY comes with higher volatility (20% greater) and a lower dividend yield of 0.8%, making it more growth-oriented and economically sensitive due to overweights in financials and technology.

YieldMax announced weekly distributions for three Performance & Distribution Target 25 ETFs tracking MSTR, NVDA, and TSLA, each with a 25% target annual income level. The distributions were announced on July 27, 2026, with ex-date of July 28 and payment date of July 29, 2026. However, the article emphasizes that distributions are variable and not guaranteed, and the funds employ call-writing strategies that cap potential gains while exposing investors to full downside losses.

Amid fluctuating investor sentiment over Fed rate hikes and legislative uncertainties, Bitcoin ETFs face significant withdrawals, highlighting the fragility of recent crypto gains

The Vanguard Russell 1000 Growth ETF (VONG) has outperformed the S&P 500 by approximately 1.37 percentage points annually since inception and 3 percentage points over the past decade, primarily due to its heavy concentration in large-cap growth and AI stocks. However, this outperformance carries concentration risk, as nearly 70% of holdings are tech companies, meaning sector weakness could quickly reverse gains.

The article compares two global ETFs: SCHF (Schwab International Equity ETF) and SPGM (State Street SPDR Portfolio MSCI Global Stock Market ETF). SCHF offers a lower expense ratio (0.03% vs 0.09%), higher dividend yield (3.06% vs 1.80%), and focuses on developed international markets, making it ideal for investors with existing U.S. exposure. SPGM provides broader diversification by combining U.S., developed, and emerging markets in one fund, resulting in stronger 5-year total returns due to exposure to U.S. mega-cap tech stocks. The choice depends on portfolio construction goals rather than performance metrics.

In the current inflationary environment (3.5% annualized), dividend growth ETFs are more attractive than bond ETFs for income investors. While bond ETFs offer fixed income with lower risk, inflation erodes purchasing power. Dividend growth stocks, particularly those with long histories of increasing dividends, provide both growing income and capital appreciation that better offset inflation's impact.

The article compares two financial sector ETFs: Vanguard Financials ETF (VFH), a low-cost broad-market index fund with 427 holdings, and ProShares Ultra Financials (UYG), a leveraged 2x ETF with 84 holdings. While UYG offers amplified returns, it carries significantly higher volatility and leverage decay risk. VFH is recommended as the better long-term choice due to its steadier performance, lower expense ratio (0.09% vs 0.94%), and superior 5-year returns ($1,696 vs $1,473 on $1,000 invested).

Vanguard offers two compelling short-term bond ETFs with identical 0.03% expense ratios. VCSH focuses on corporate bonds with a higher 4.50% yield but greater volatility, while BSV provides broader diversification with 70% Treasury exposure and a 4.00% yield. The choice depends on risk tolerance: VCSH suits yield-seeking investors, while BSV appeals to conservative investors prioritizing capital preservation.

Despite current market headwinds including Middle East conflict, AI labor concerns, and low consumer confidence, historical data supports long-term S&P 500 investing. The Vanguard S&P 500 ETF delivered 306% total returns over the past decade despite multiple crises, demonstrating that patient, long-term investors benefit from staying invested rather than timing the market.